UBS Group AG - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 26 filers reported holding EFFECTOR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,924
-21.6%
9,874
-53.9%
0.00%
Q1 2023$7,559
-33.1%
21,414
-18.5%
0.00%
Q4 2022$11,293
+25.5%
26,263
+58.6%
0.00%
Q3 2022$9,000
+800.0%
16,558
+11643.3%
0.00%
Q1 2022$1,000
-95.0%
141
-94.1%
0.00%
Q4 2021$20,0002,4010.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$9,687,0004.74%
Abingworth LLP 4,822,114$6,462,0002.07%
OUP Management Co., LLC 1,025,697$1,456,0002.00%
Column Group LLC 4,309,329$6,119,0001.30%
Evolution Capital Management LLC 527,885$750,0001.12%
SECTORAL ASSET MANAGEMENT INC 2,382,644$3,383,0000.68%
Parallel Advisors, LLC 1,693,559$2,405,0000.11%
RESOLUTE FINANCIAL, LLC 30,000$43,0000.04%
Oasis Management Co Ltd. 100,000$142,0000.02%
Blackstone Inc. 1,308,587$1,858,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders